AI research reveals two distinct types of prostate cancer, paving the way for more personalized treatments. This breakthrough could revolutionize patient care, offering targeted therapies for improved outcomes. The discovery also underscores the potential of AI in healthcare, suggesting a future where machine learning aids in disease classification and treatment.
